OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Down‐regulation of RCC1 sensitizes immunotherapy by up‐regulating PD‐L1 via p27kip1/CDK4 axis in non‐small cell lung cancer
Xiaozhu Zeng, Maoxi Zhong, Yumeng Yang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 8, pp. 4136-4147
Open Access | Times Cited: 18

Showing 18 citing articles:

Massively parallel interrogation of human functional variants modulating cancer immunosurveillance
Ying Liu, Yongshuo Liu, Xuran Niu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Decoding oncogenic secrets of regulator of chromosome condensation 1: A breakthrough mechanistic evidence from breast and lung cancer models
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319748-e0319748
Open Access

Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2
Mingzhi Zhuang, Fengyue Li, Hong Liang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 3

MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma
Anna Kan, Shuang Liu, Minke He, et al.
JHEP Reports (2023) Vol. 6, Iss. 1, pp. 100939-100939
Open Access | Times Cited: 6

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
Changwu Wu, Yingjuan Duan, Siming Gong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7374-7374
Open Access | Times Cited: 13

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
Deqian Xie, Bowen Jiang, Shijin Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability
Yunfei Wu, Zhijie Xu, Xiaoyi Chen, et al.
Cancer Medicine (2023) Vol. 12, Iss. 19, pp. 19889-19903
Open Access | Times Cited: 4

The role of targeting CDK4/6 in cancer immunotherapy
Mengyu Sun, Dong Lin, Yu Wang, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1

Inhibition of IDH3α Enhanced the Efficacy of Chemoimmunotherapy by Regulating Acidic Tumor Microenvironments
Lingling Zhang, Yang Song, Xiaoyan Dai, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1802-1802
Open Access | Times Cited: 3

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
Yuxiang Deng, Long Yu, Yujie Zhao, et al.
Pathology & Oncology Research (2021) Vol. 27
Open Access | Times Cited: 7

The intricate roles of RCC1 in normal cells and cancer cells
Jing Li, Hang Fai Kwok
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 83-93
Closed Access | Times Cited: 4

Nup50 plays more than one instrument
Guillaume Holzer, Wolfram Antonin
Cell Cycle (2022) Vol. 21, Iss. 17, pp. 1785-1794
Open Access | Times Cited: 3

Pan‐cancer analysis reveals the pro‐oncogenic role of N6‐methyladenosine (m6A)‐regulated NTMT1 in head and neck squamous cell carcinoma
Chunhong Zhao, Min Yu, Yujie Li
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access

Systematic Pan-cancer Analysis on the Expression and Role of RCC1/SNHG3/SNHG12
Yan Zhang, Kai Hu, Huomei Yu, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top